Treatment for Pleural and Peritoneal Mesothelioma
Recent phase 3 clinical trial data suggest that surgery and chemotherapy may lead to worse survival outcomes than chemotherapy alone for certain patients with pleural mesothelioma. Additionally, data on other systemic therapy regimens for the treatment of mesothelioma have been recently published.
NCCN Guidelines® Insights - Mesothelioma: Pleural, Version 1.2024
These NCCN Guidelines Insights highlight significant updates to the NCCN Guidelines for Mesothelioma: Pleural, including revised guidance on disease classification and systemic therapy options.
NCCN Guidelines® Insights - Malignant Pleural Mesothelioma, Version 3.2016

These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM). These NCCN Guidelines Insights discuss systemic therapy regimens and surgical controversies for MPM.

Seattle Cancer Care Alliance - 2015 Thoracic Oncology Symposium

This symposium has been designed to bring up-to-date scientific information to clinicians involved in the care of patients with thoracic malignancies, including Lung Cancer, Mesothelioma, and Esophageal Cancer.

Subscribe to RSS - Mesothelioma